Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eco Animal Health GroupFRA:LWA -0.91%52 EV-to-OCF is 7.08 as of Aug. 28, 2026, which is 59% below its 10-year median of 17.18. GuruFocus rates FRA:LWA with a GF Score™ of 52/100 and a GF Value™ of €1.11. The stock has 3 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Eco Animal Health Group ranks better than 59.54% on this metric.
The historical rank and industry rank for Eco Animal Health Group's EV-to-OCF or its related term are showing as below:
FRA:LWA'
s EV-to-OCF Range Over the Past 10 Years
Min: -203.67 Med: 17.18 Max: 125.09
Current: 7.01
During the past 13 years, the highest EV-to-OCF of Eco Animal Health Group was 125.09. The lowest was -203.67. And the median was 17.18.
FRA:LWA's EV-to-OCF is ranked better than 59.54% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 10.505
vs FRA:LWA: 7.01
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eco Animal Health Group (FRA:LWA) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Eco Animal Health Group's PE Ratio (TTM) for today is calculated as:
Eco Animal Health Group's share price for today is €1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eco Animal Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.037.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eco Animal Health Group EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Eco Animal Health Group's EV-to-OCF falls into.
Eco Animal Health Group's current Enterprise Value is €62.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eco Animal Health Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €8.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eco Animal Health Group (FRA:LWA) has a EV-to-OCF of 7.08 as of Aug. 28, 2026. This is 59% below median its historical median of 17.18. According to the industry distribution chart, Eco Animal Health Group ranks #407 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 40.5%.
Is Eco Animal Health Group's EV-to-OCF too high?
Eco Animal Health Group's current EV-to-OCF of 7.08 is 59% below median its 10-year median of 17.18. The Drug Manufacturers industry median EV-to-OCF is 10.51. Eco Animal Health Group's value of 7.08 is 32.6% below this industry median. Based on the distribution chart, Eco Animal Health Group ranks #407 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eco Animal Health Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's EV-to-OCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eco Animal Health Group ranks #407 out of 1006 companies for EV-to-OCF. This puts Eco Animal Health Group in the upper half of its industry. The industry median EV-to-OCF is 10.51. Eco Animal Health Group's value of 7.08 is 32.6% below this benchmark. While the company's 10-year median is 17.18 vs. the industry median of 10.51, Eco Animal Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.51, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eco Animal Health Group's current EV-to-OCF of 7.08 is 32.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current EV-to-OCF is 7.08, which is 59% below median its own 10-year median of 17.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Eco Animal Health Group (FRA:LWA) has a current EV-to-OCF of 7.08. The stock's GF Value™ is €1.11, compared to a current price of €1.09 — trading 1.8% below its estimated fair value. The current EV-to-OCF is 7.08, which is 59% below median its 10-year median of 17.18 and 32.6% below the Drug Manufacturers industry median of 10.51. Eco Animal Health Group's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Eco Animal Health Group (FRA:LWA), the current EV-to-OCF is 7.08 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eco Animal Health Group (FRA:LWA) Overvalued in 2026?
Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued.
The current stock price of €1.09 is trading 1.8% below its estimated GF Value™ of €1.11.
Key valuation signals for FRA:LWA:
EV-to-OCF: 7.08 (59% below median its 10-year median of 17.18)
GF Value™: €1.11 vs. price of €1.09 (1.8% below fair value)
Industry Position: 32.6% below the Drug Manufacturers median (#407 of 1006)
No single metric tells the full story. See the FRA:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
52GF Score
Get the complete analysis for FRA:LWA
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LWA has been successfully added to your 
